Morello, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.240
EU - Europa 538
AS - Asia 231
SA - Sud America 5
OC - Oceania 3
AF - Africa 2
Totale 2.019
Nazione #
US - Stati Uniti d'America 1.229
IT - Italia 209
CN - Cina 108
UA - Ucraina 88
HK - Hong Kong 80
DE - Germania 72
FI - Finlandia 56
IE - Irlanda 34
GB - Regno Unito 26
SE - Svezia 19
IN - India 17
BE - Belgio 15
SG - Singapore 14
CA - Canada 11
FR - Francia 8
GR - Grecia 4
AU - Australia 3
CO - Colombia 3
TR - Turchia 3
BR - Brasile 2
HR - Croazia 2
NL - Olanda 2
RU - Federazione Russa 2
TH - Thailandia 2
AZ - Azerbaigian 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 2.019
Città #
Fairfield 175
Chandler 110
Ashburn 101
Woodbridge 86
New York 82
Hong Kong 80
Jacksonville 79
Ann Arbor 77
Seattle 76
Wilmington 73
Brescia 66
Princeton 57
Helsinki 55
Houston 52
Cambridge 45
Beijing 42
Dublin 34
Shanghai 25
Brussels 15
Des Moines 13
Pune 12
Milan 11
Barlassina 10
Nanjing 8
San Diego 7
Toronto 7
Jinan 6
London 5
Rome 5
San Francisco 5
Shenyang 5
Changsha 4
Falkenstein 4
Pescara 4
Turin 4
Athens 3
Brooklyn 3
Chicago 3
Chiswick 3
Dearborn 3
Hebei 3
Jiaxing 3
Kocaeli 3
Leawood 3
Melbourne 3
Redwood City 3
Tianjin 3
Viterbo 3
Bucaramanga 2
Casanova Lonati 2
Cetraro 2
Core 2
Guangzhou 2
Haikou 2
Halifax 2
Lovere 2
Mazzano 2
Mumbai 2
Ningbo 2
Pavia 2
Singapore 2
Storo 2
São Paulo 2
Amsterdam 1
Aosta 1
Augusta 1
Bangkok 1
Bergamo 1
Boardman 1
Bogotá 1
Borås 1
Boston 1
Cachan 1
Castiglione Delle Stiviere 1
Centurion 1
Civitavecchia 1
Colombo 1
Cremona 1
Darfo 1
Fiesole 1
Fiorenzuola D'arda 1
Florence 1
Gossolengo 1
Hangzhou 1
Hanover 1
Hillsborough 1
Hounslow 1
Kilburn 1
Kish 1
Kunming 1
La Spezia 1
Landshut 1
Lappeenranta 1
Lequio Tanaro 1
Lincoln 1
Los Angeles 1
Margherita di Savoia 1
Montecatini Terme 1
Moscow 1
North York 1
Totale 1.546
Nome #
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 102
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 101
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 97
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 89
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 81
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 77
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 76
Advances in CMV Management: A Single Center Real-Life Experience 72
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 64
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 64
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 62
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 56
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 55
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 53
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 52
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 52
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 48
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 46
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 44
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 43
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 42
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 40
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 40
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 38
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 38
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 36
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 35
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 29
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 27
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 25
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 23
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 22
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 17
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 17
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 14
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 11
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 10
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 10
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 9
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 9
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 9
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 9
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 7
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 5
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 5
Nutritional strategies to improve VRE control 4
Totale 2.089
Categoria #
all - tutte 13.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 20 20
2019/2020374 22 5 8 29 28 38 32 35 47 70 24 36
2020/2021489 13 28 13 85 22 63 32 49 44 79 35 26
2021/2022293 25 17 5 26 8 25 12 27 13 51 20 64
2022/2023382 44 11 17 36 35 79 2 44 44 12 28 30
2023/2024470 32 14 51 34 33 145 27 24 100 9 1 0
Totale 2.089